Adrenergic receptor systems and unscheduled DNA synthesis in the rat brain

A. G. Sadile, C. Lamberti-D'Mello, A. Cerbone, S. Amoroso, L. Annunziato, T. Menna, C. Buono, A. Giuditta

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Two experiments were carried out in the albino rat to investigate the role of brain adrenergic systems in DNA remodeling. Adult maw Sprague-Dawley rats were given an intraventricular micreoinjection of an adronergic drug or vehicle followed 2 h later by the intraventricular injection of 50 μCi of [3H-methyl]tinymkline. The rats were sacrificed 0.5 h after the injection of the radioactive tracer. The rate of DNA synthesis was determined by measuring the amount of radioactive precursor incorporated into the DNA extracted from homogenates of several brain areas. In Experiment 1, at time 0 rats received the alpha-adrenergic antagonist phentolamine (5 μg), the beta antagonist propranolol (10 μg), the alpha agonist phenylephrine (1 μg), the beta agonist isoproterenol (12.5 μg), or the vehicle. The latter decreased UBDS in neocortex, and increased it in the septum, neostriaturn, hypothalamus, cerebellum, and rest of the brain. The alpha and beta agonists and antagonists induced several significant effects, depending on the brain region. In Experiment 2, rats were bilateraly lesioned in the dorsal noradrenergic bundle (DNB) by injection or 8-hydroxydopamine or were sham lesioned. One week later, at time 0 they were given the alpha agonist phenylephrine (1 μg), the beta agonist isoproterenol (12.5 μg), or the vehicle. The DNB-lesionsd rats showed a higher UBDS in the hippocampus, neocortex, and hypothalamus, which was reversed by the alpha or time beta agonist The results suggest an influence of the DNB, probably as a tonic Inhibitor of UBDS in time hippocampus and the hypothalamus which, in turn, are likely to be mediated by beta- and alpha-adrenergic receptors. In addition, a phasic inhibitory effect seems to be mediated by beta and alpha receptors in the neocortex, and by beta receptors in the cerebellum. A modulatory role of central adrenergic systems on unscheduled brain DNA synthesis may be inferred from these findings.

Original languageEnglish
Pages (from-to)139-148
Number of pages10
JournalBrain Research Bulletin
Volume37
Issue number2
DOIs
Publication statusPublished - 1995

Fingerprint

Adrenergic Receptors
Neocortex
DNA
Hypothalamus
Brain
Phenylephrine
Isoproterenol
Adrenergic Agents
Cerebellum
Hippocampus
Hydroxydopamines
Radioactive Tracers
Intraventricular Injections
Adrenergic alpha-Antagonists
Receptors, Adrenergic, alpha
Injections
Phentolamine
Receptors, Adrenergic, beta
Propranolol
Sprague Dawley Rats

Keywords

  • 6-Hydroxydopamine
  • H-Thymidine incorporation
  • Alpha- and beta-Adrenergic receptors
  • Deoxyribonucleic acid
  • Dorsal noradrenergic bundle
  • Isoproterenol
  • Phentolamine
  • Phenylephrine
  • Propranolol

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Sadile, A. G., Lamberti-D'Mello, C., Cerbone, A., Amoroso, S., Annunziato, L., Menna, T., ... Giuditta, A. (1995). Adrenergic receptor systems and unscheduled DNA synthesis in the rat brain. Brain Research Bulletin, 37(2), 139-148. https://doi.org/10.1016/0361-9230(94)00267-5

Adrenergic receptor systems and unscheduled DNA synthesis in the rat brain. / Sadile, A. G.; Lamberti-D'Mello, C.; Cerbone, A.; Amoroso, S.; Annunziato, L.; Menna, T.; Buono, C.; Giuditta, A.

In: Brain Research Bulletin, Vol. 37, No. 2, 1995, p. 139-148.

Research output: Contribution to journalArticle

Sadile, AG, Lamberti-D'Mello, C, Cerbone, A, Amoroso, S, Annunziato, L, Menna, T, Buono, C & Giuditta, A 1995, 'Adrenergic receptor systems and unscheduled DNA synthesis in the rat brain', Brain Research Bulletin, vol. 37, no. 2, pp. 139-148. https://doi.org/10.1016/0361-9230(94)00267-5
Sadile, A. G. ; Lamberti-D'Mello, C. ; Cerbone, A. ; Amoroso, S. ; Annunziato, L. ; Menna, T. ; Buono, C. ; Giuditta, A. / Adrenergic receptor systems and unscheduled DNA synthesis in the rat brain. In: Brain Research Bulletin. 1995 ; Vol. 37, No. 2. pp. 139-148.
@article{2f7910709fa24715809a4a493d4b4a2b,
title = "Adrenergic receptor systems and unscheduled DNA synthesis in the rat brain",
abstract = "Two experiments were carried out in the albino rat to investigate the role of brain adrenergic systems in DNA remodeling. Adult maw Sprague-Dawley rats were given an intraventricular micreoinjection of an adronergic drug or vehicle followed 2 h later by the intraventricular injection of 50 μCi of [3H-methyl]tinymkline. The rats were sacrificed 0.5 h after the injection of the radioactive tracer. The rate of DNA synthesis was determined by measuring the amount of radioactive precursor incorporated into the DNA extracted from homogenates of several brain areas. In Experiment 1, at time 0 rats received the alpha-adrenergic antagonist phentolamine (5 μg), the beta antagonist propranolol (10 μg), the alpha agonist phenylephrine (1 μg), the beta agonist isoproterenol (12.5 μg), or the vehicle. The latter decreased UBDS in neocortex, and increased it in the septum, neostriaturn, hypothalamus, cerebellum, and rest of the brain. The alpha and beta agonists and antagonists induced several significant effects, depending on the brain region. In Experiment 2, rats were bilateraly lesioned in the dorsal noradrenergic bundle (DNB) by injection or 8-hydroxydopamine or were sham lesioned. One week later, at time 0 they were given the alpha agonist phenylephrine (1 μg), the beta agonist isoproterenol (12.5 μg), or the vehicle. The DNB-lesionsd rats showed a higher UBDS in the hippocampus, neocortex, and hypothalamus, which was reversed by the alpha or time beta agonist The results suggest an influence of the DNB, probably as a tonic Inhibitor of UBDS in time hippocampus and the hypothalamus which, in turn, are likely to be mediated by beta- and alpha-adrenergic receptors. In addition, a phasic inhibitory effect seems to be mediated by beta and alpha receptors in the neocortex, and by beta receptors in the cerebellum. A modulatory role of central adrenergic systems on unscheduled brain DNA synthesis may be inferred from these findings.",
keywords = "6-Hydroxydopamine, H-Thymidine incorporation, Alpha- and beta-Adrenergic receptors, Deoxyribonucleic acid, Dorsal noradrenergic bundle, Isoproterenol, Phentolamine, Phenylephrine, Propranolol",
author = "Sadile, {A. G.} and C. Lamberti-D'Mello and A. Cerbone and S. Amoroso and L. Annunziato and T. Menna and C. Buono and A. Giuditta",
year = "1995",
doi = "10.1016/0361-9230(94)00267-5",
language = "English",
volume = "37",
pages = "139--148",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Adrenergic receptor systems and unscheduled DNA synthesis in the rat brain

AU - Sadile, A. G.

AU - Lamberti-D'Mello, C.

AU - Cerbone, A.

AU - Amoroso, S.

AU - Annunziato, L.

AU - Menna, T.

AU - Buono, C.

AU - Giuditta, A.

PY - 1995

Y1 - 1995

N2 - Two experiments were carried out in the albino rat to investigate the role of brain adrenergic systems in DNA remodeling. Adult maw Sprague-Dawley rats were given an intraventricular micreoinjection of an adronergic drug or vehicle followed 2 h later by the intraventricular injection of 50 μCi of [3H-methyl]tinymkline. The rats were sacrificed 0.5 h after the injection of the radioactive tracer. The rate of DNA synthesis was determined by measuring the amount of radioactive precursor incorporated into the DNA extracted from homogenates of several brain areas. In Experiment 1, at time 0 rats received the alpha-adrenergic antagonist phentolamine (5 μg), the beta antagonist propranolol (10 μg), the alpha agonist phenylephrine (1 μg), the beta agonist isoproterenol (12.5 μg), or the vehicle. The latter decreased UBDS in neocortex, and increased it in the septum, neostriaturn, hypothalamus, cerebellum, and rest of the brain. The alpha and beta agonists and antagonists induced several significant effects, depending on the brain region. In Experiment 2, rats were bilateraly lesioned in the dorsal noradrenergic bundle (DNB) by injection or 8-hydroxydopamine or were sham lesioned. One week later, at time 0 they were given the alpha agonist phenylephrine (1 μg), the beta agonist isoproterenol (12.5 μg), or the vehicle. The DNB-lesionsd rats showed a higher UBDS in the hippocampus, neocortex, and hypothalamus, which was reversed by the alpha or time beta agonist The results suggest an influence of the DNB, probably as a tonic Inhibitor of UBDS in time hippocampus and the hypothalamus which, in turn, are likely to be mediated by beta- and alpha-adrenergic receptors. In addition, a phasic inhibitory effect seems to be mediated by beta and alpha receptors in the neocortex, and by beta receptors in the cerebellum. A modulatory role of central adrenergic systems on unscheduled brain DNA synthesis may be inferred from these findings.

AB - Two experiments were carried out in the albino rat to investigate the role of brain adrenergic systems in DNA remodeling. Adult maw Sprague-Dawley rats were given an intraventricular micreoinjection of an adronergic drug or vehicle followed 2 h later by the intraventricular injection of 50 μCi of [3H-methyl]tinymkline. The rats were sacrificed 0.5 h after the injection of the radioactive tracer. The rate of DNA synthesis was determined by measuring the amount of radioactive precursor incorporated into the DNA extracted from homogenates of several brain areas. In Experiment 1, at time 0 rats received the alpha-adrenergic antagonist phentolamine (5 μg), the beta antagonist propranolol (10 μg), the alpha agonist phenylephrine (1 μg), the beta agonist isoproterenol (12.5 μg), or the vehicle. The latter decreased UBDS in neocortex, and increased it in the septum, neostriaturn, hypothalamus, cerebellum, and rest of the brain. The alpha and beta agonists and antagonists induced several significant effects, depending on the brain region. In Experiment 2, rats were bilateraly lesioned in the dorsal noradrenergic bundle (DNB) by injection or 8-hydroxydopamine or were sham lesioned. One week later, at time 0 they were given the alpha agonist phenylephrine (1 μg), the beta agonist isoproterenol (12.5 μg), or the vehicle. The DNB-lesionsd rats showed a higher UBDS in the hippocampus, neocortex, and hypothalamus, which was reversed by the alpha or time beta agonist The results suggest an influence of the DNB, probably as a tonic Inhibitor of UBDS in time hippocampus and the hypothalamus which, in turn, are likely to be mediated by beta- and alpha-adrenergic receptors. In addition, a phasic inhibitory effect seems to be mediated by beta and alpha receptors in the neocortex, and by beta receptors in the cerebellum. A modulatory role of central adrenergic systems on unscheduled brain DNA synthesis may be inferred from these findings.

KW - 6-Hydroxydopamine

KW - H-Thymidine incorporation

KW - Alpha- and beta-Adrenergic receptors

KW - Deoxyribonucleic acid

KW - Dorsal noradrenergic bundle

KW - Isoproterenol

KW - Phentolamine

KW - Phenylephrine

KW - Propranolol

UR - http://www.scopus.com/inward/record.url?scp=0028917112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028917112&partnerID=8YFLogxK

U2 - 10.1016/0361-9230(94)00267-5

DO - 10.1016/0361-9230(94)00267-5

M3 - Article

C2 - 7606489

AN - SCOPUS:0028917112

VL - 37

SP - 139

EP - 148

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 2

ER -